Teleflex wins expanded FDA clearance for PAD device

08/2/2013 | (Boston)

The FDA has granted Teleflex clearance for new versions of its Arrow GPSCath Balloon Dilatation Catheter that have 80-centimeter lengths and higher burst-pressure ratings. The device, which was acquired by Teleflex through its acquisition of Hotspur Technologies last year, is used to treat patients with peripheral artery disease.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC